Transduction efficiency of MLV but not of HIV-1 vectors is pseudotype dependent on human primary T lymphocytes

Journal of Molecular Medicine

Volumn 81, Issue 12, 2003, Pages 801-810

  Mühlebach, Michael D ^a,f   Schmitt, Isabel ^a   Steidl, Stefanie ^a   Stitz, Jörn ^a,e   Schweizer, Matthias ^a   Blankenstein, Thomas ^b,c   Cichutek, Klaus ^a   Uckert, Wolfgang ^b,d  

^a PAUL EHRLICH INSTITUT   (Germany)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^c FREIE UNIVERSITÄT BERLIN   (Germany)

^d HUMBOLDT UNIVERSITY   (Germany)

^e STANFORD UNIVERSITY   (United States)

^f GOETHE UNIVERSITY   (Germany)

Author keywords

Gene transfer; Human T lymphocyte transduction; Lentiviral vectors; Retroviral vectors; Vector pseudotype

Indexed keywords

GREEN FLUORESCENT PROTEIN; RETROVIRUS VECTOR;

ARTICLE; CELL ACTIVATION; CELL SUBPOPULATION; COMPARATIVE STUDY; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MARKER GENE; MOLONEY LEUKEMIA ONCOVIRUS; T LYMPHOCYTE; TITRIMETRY; VIRUS ENVELOPE; VIRUS TYPING;

CD4-CD8 RATIO; CELLS, CULTURED; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HIV-1; HUMANS; LEUKEMIA VIRUS, MURINE; LUMINESCENT PROTEINS; LYMPHOCYTE ACTIVATION; RETROVIRIDAE; T-LYMPHOCYTES; TRANSDUCTION, GENETIC; VIRAL ENVELOPE PROTEINS;

EID: 0347986578     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00109-003-0491-2     Document Type: Article

References (52)

1. Kalle C von, Kiem HP, Goehle S, Darovsky B, Heimfeld S, Torok-Storb B, Schuening FG (1994) Increased gene transfer into human hematopoietic progenitor cells by extended in vitro exposure to a pseudotyped retroviral vector. Blood 84:2890-2897
2. Bauer TR Jr, Miller AD, Hickstein DD (1995) Improved transfer of the leukocyte integrin CD18 subunit into hematopoietic cell lines by using retroviral vectors having a gibbon ape leukemia virus envelope. Blood 86:2379-2387
3. Lam JS, Reeves ME, Cowherd R, Rosenberg SA, Hwu P (1996) Improved gene transfer into human lymphocytes using retroviruses with the gibbon ape leukemia virus envelope. Hum Gene Ther 7:1415-1422
4. Kavanaugh MP, Miller DG, Zhang W, Kozak SL, Kabat D, Miller AD (1994) Cell-surface receptors for gibbon ape leukemia virus and amphotropic murine retrovirus are inducible sodium-dependent phosphate symporters. Proc Natl Acad Sci USA 91:7071-7075
5. + T lymphocytes by MuLV-10A1 retrovirus pseudotype. Hum Gene Ther 11:1005-1014
6. Farson D, McGuinnes R, Dull T, Limoli K, Lazar R, Jalali S, Reddy S, Pennathur-Das R, Broad D, Finer M (1999) Large scale manufacturing of safe and efficient retrovirus packaging lines for use in immunotherapy protocols. J Gene Med 1:195-209
7. + T lymphocytes. J Gene Med 2:409-415
8. Zhou P, Lee J, Moore P, Brasky KM (2001) High-efficiency gene transfer into rhesus macaque primary T lymphocytes by combining 32°C centrifugation and CH-296-coated plates: effect of gene transfer protocol on T-cell homing receptor expression. Hum Gene Ther 12:1843-1855
9. Miller DG, Adam MA, Miller AD (1990) Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol 10:4239-4242
10. Roe T, Reynolds TC, Yu G, Brown PO (1993) Integration of murine leukemia virus DNA depends on mitosis. EMBO J 12:2099-2108
11. Vigna E, Naldini L (2000) Lentiviral vectors: excellent tools for experimental gene transfer and promising candidates for gene therapy. J Gene Med 2:308-316
12. Sutton RE, Reitsma MJ, Uchida N, Brown PO (1999) Transduction of human immunodeficiency virus type 1-based vectors is cell cycle dependent. J Virol 73:3649-3660
13. Kootstra NA, Zwart BM, Schuitemaker H (2000) Diminished human immunodeficiency virus type 1 reverse transcription and nuclear transport in primary macrophages arrested in early G (1) phase of the cell cycle. J Virol 74:1712-1717
14. Neil S, Martin F, Ideda Y, Collins M (2001) Postentry restriction to human immunodeficiency virus-based vector transduction in human monocytes. J Virol 75:5448-5456
15. Salmon P, Kindler V, Ducrey O, Chapuis B, Zubler RH, Trono D (2000) High-level transgene expression in human hematopoietic progenitors and differentiated blood lineages after transduction with improved lentiviral vectors. Blood 96:3392-3398
16. Zennou V, Petit C, Guetard D, Nerhbass U, Montagnier L, Chameau P (2000) HIV-1 genome nuclear import is mediated by a central DNA flap. Cell 101:173-185
17. Manganini M, Serafini M, Bambacioni F, Casati C, Erba E, Follenzi A, Naldini L, Bernasconi S, Gaipa G, Rambaldi A, Biondi A, Golay J, Introna M (2002) A human immunodeficiency virus type 1 pol gene-derived sequence (cPPT/CTS) increases the efficiency of transduction of human nondividing monocytes and T lymphocytes by lentiviral vectors. Hum Gene Ther 13:1793-1807
18. Ib phase of the cell cycle is required for completion of human immunodeficiency virus type 1 reverse transcription in T cells. J Virol 72:3161-3168
19. Unutmaz D, Ramani VNK, Marmon S (1999) Cytokine signals are sufficient for HIV-1 infection of resting human T lymphocytes. J Exp Med 189:1735-1746
20. Dardalhon V, Jaleco S, Kinet S, Herpers B, Steinberg M, Ferrand C, Froger D, Leveau C, Tiberghien P, Charneau P, Noraz N, Taylor N (2001) IL-7 differentially regulates cell cycle progression and HIV-1-based vector infection in neonatal and adult CD4+ T cells. Proc Natl Acad Sci USA 98:9277-9282
21. Ducrey-Rundquist O, Guyader M, Trono D. Modalities of interleukin-7-induced human immunodeficiency virus permissiveness in quiescent T lymphocytes. J Virol 2002:76:9103-9111
22. Scripture-Adams DD, Brooks DG, Korin YD, Zack JA (2002) Interleukin-7 induces expression of latent human immunodeficiency virus type 1 with minimal effects on T-cell phenotype. J Virol 76:13077-13082
23. Maurice M, Verhoeyen E, Salmon P, Trono D, Russell SJ, Cosset FL (2002) Efficient gene transfer into human primary blood lymphocytes by surface-engineered lentiviral vectors that display a T cell-activating polypeptide. Blood 99:2342-2350
24. Hanawa H, Kelly PF, Nathwani AC, Persons DA, Vandergriff JA, Hargrove P, Vanin EF, Nienhuis AW (2002) Comparison of various envelope proteins for their ability to pseudotype lentiviral vectors and transduce primitive hematopoietic cells from human blood. Mol Ther 5:242-251
25. Chinnasamy D, Chinnasamy N, Enriquez MJ, Otsu M, Morgan RA, Candotti F (2000) Lentiviral-mediated gene transfer into human lymphocytes: role of HIV-1 accessory proteins. Blood 96:1309-1316
26. Costello E, Munoz M, Buetti E, Meylan PR, Diggelmann H, Thali M (2000) Gene transfer into stimulated and unstimulated T lymphocytes by HIV-1-derived lentiviral vectors. Gene Ther 7:596-604
27. Stitz J, Buchholz CJ, Engelstädter M, Uckert W, Bloemer U, Schmitt I, Cichutek K (2000) Lentiviral vectors pseudotyped with envelope glycoproteins derived from gibbon ape leukemia virus and murine leukemia virus 10A1. Virology 273:16-20
28. Miller AD, Rosman GJ (1989) Improved retroviral vectors for gene transfer and expression. Biotechniques 7:980-990
29. Miller AD, Garcia JV, von Suhr N, Lynch CM, Wilson C, Eiden MV (1991) Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus. J Virol 65:2220-2224
30. Klein D, Indraccolo S, Von Rombs K, Amadori A, Salmons B, Gunzburg WH (1997) Rapid identification of viable retrovirus-transduced cells using the green fluorescent protein as a marker. Gene Ther 4:1256-1260
31. Uckert W, Pedersen L, Günzburg W (2000) Green fluorescent protein retroviral vector: generation of high-titer producer cells and virus supernatant. In: Walther W, Stein U (eds), Methods in molecular medicine, vol 35. Humana, Totowa, 271-281
32. Soneoka Y, Cannon PM, Ramsdale EE, Griffiths JC, Romano G, Kingsman SM, Kingsman AJ (1995) A transient three-plasmid expression system for the production of high titer retroviral vectors. Nucleic Acids Res 23:628-633
33. Naldini L, Blömer U, Gage FH, Trono D, Verma IM (1996) Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc Natl Acad Sci USA 93:11382-11388
34. Stitz J, Mühlebach MD, Blömer U, Scherr M, Selbert M, Wehner P, Steidl S, Schmitt I, König R, Schweizer M, Cichutek K (2001) A novel lentivirus vector derived from apathogenic simian immunodeficiency virus. Virology 201:191-197
35. Naldini L, Blömer U, Gallay P, Ory D, Mulligan R, Gage FH, Venna IM, Trono D (1996) In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272:263-267
36. Cosset FL, Takeuchi Y, Battini JL, Weiss RA, Collins MK (1995) High titer packaging cells producing recombinant retroviruses resistant to human serum. J Virol 69:7430-7436
37. Stitz J, Steidl S, Merget-Millitzer H, König R, Muller P, Nocken F, Engelstadter M, Bobkova M, Schmitt I, Kurth R, Buchholz CJ, Cichutek K (2000) MLV-derived retroviral vectors selective for CD4-expressing cells and resistant to neutralization by sera from HIV-infected patients. Virology 267:229-236
38. Laer D von, Thomsen S, Vogt B, Donath M, Kruppa J, Rein A, Ostertag W, Stocking C (1998) Entry of amphotropic and 10A1 pseudotyped murine retroviruses is restricted in hematopoietic stem cell lines. J Virol 72:1424-1430
39. Miletic H, Bruns M, Tsiakas K, Vogt, B, Rezai R, Baum C, Kuhlke K, Cosset FL, Ostertag W, Lother H, von Laer D (1999) Retroviral vectors pseudotyped with lymphocytic choriomeningitis virus. J Virol 73:6114-6116
40. Schnierle BS, Stitz J, Bosch V, Nocken F, Merget-Millitzer H, Engelstadter M, Kurth R, Groner B, Cichutek K (1997) Pseudotyping of murine leukemia virus with the envelope glycoproteins of HIV generates a retroviral vector with specificity of infection for CD4-expressing cells. Proc Natl Acad Sci USA 94:8640-8645
41. Annenkov AE, Daly GM, Chernajovsky Y (2002) Highly efficient gene transfer into antigen-specific primary mouse lymphocytes with replication-deficient retrovirus expressing the 10A1 envelope protein. J Gene Med 4:133-140
42. Gallardo HF, Tan C, Ory D, Sadelain M (1997) Recombinant retrovirus pseudotyped with the vesicular stomatitis virus glycoprotein mediate both stable gene transfer and pseudo-transduction in human peripheral blood lymphocytes. Blood 90:952-957
43. Rebel VI, Tanaka M, Lee JS, Harnett S, Pulsipher M, Nathan DG, Mulligan RC, Sieff CA (1999) One-day ex vivo culture allows effective gene transfer into human nonobese diabetic/severe combined immuno-deficient repopulating cells using high-titer vesicular stomatitis virus G protein pseudotyped retrovirus. Blood 93:22217-22224
44. Janssens W, Chuah MKL, Naldini L, Follenzi A, Collen D, Saint-Remy J-M, Vandendriessche T (2003) Efficiency of onco-retroviral and lentiviral gene transfer into primary mouse and human B-lymphocytes is pseudotype dependent. Hum Gene Ther 14:263-276
45. Landau NR, Page KA, Littman DR (1991) Pseudotyping with human T-cell leukemia virus type I broadens the human immunodeficiency virus host range. J Virol 65:162-169
46. Lusso P, Di Marzo Veronese F, Ensoli B, Franchini G, Jemma C, DeRosso SE, Kalyanaraman VS, Gallo RC (1990) Expanded HIV-1 cellular tropism by phenotypic mixing with murine endogenous retroviruses. Science 247:848-852
47. Woods NB, Muessig A, Schmidt M, Flygare J, Olsson K, Salmon P, Trono D, von Kalle C, Karlsson S (2003) Lentiviral vector transduction of NOD/SCID repopulating cells results in multiple vector integrations per transduced cell: risk of insertational mutagenesis. Blood 101:1284-1289
48. Hamaguchi I, Woods NB, Panagopoulos I, Andersson E, Mikkola H, Fahlman C, Zufferey R, Carlsson L, Trono D, Karlsson S (2000) Lentivirus vector gene expression during ES cell-derived hematopoietic development in vitro. J Virol 74:10778-10784
49. Christodoulopoulos I, Cannon PM (2001) Sequences in the cytoplasmic tail of the gibbon ape leukemia virus envelope protein that prevent its incorporation into lentivirus vectors. J Virol 75:4129-4138
50. Giguere JF, Paquette JS, Bounou S, Cantin R, Tremblay MJ (2002) New insights into the functionality of a virion-anchored host cell membrane protein: CD28 versus HIV type 1. J Immunol 169:2762-2771
51. Saphire ACS, Bobardt MD, Gallay PA (1999) Host cyclophilin A mediates HIV-1 attachment to target cells via heparans. EMBO J 23:6771-6785
52. Guibinga GH, Miyanohara A, Esko JD, Friedmann T (2002) Cell surface heparan sulfate is a receptor for attachment of envelope protein-free retrovirus-like particles and VSV-G pseudotyped MLV-derived retrovirus vectors to target cells. Mol Ther 5:538-546